Loading publications…
The last 5 uploaded publications
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, Ángel Cequier, Didier Carrié, Jan J. Piek, Ad J. van Boven, Marcello Dominici, Dariusz Dudek, Dougal McClean, Steffen Helqvist, Michael Haude, Sebastian Reith, Manuel Almeida, Gianluca Campo, Andrés Íñiguez, Manel Sabaté, Stephan Windecker, Yoshinobu Onuma (2016). Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. The Lancet, 388(10059), pp. 2479-2491, DOI: 10.1016/s0140-6736(16)32050-5.
Article146 days agoA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.
Patrick W. Serruys, P. Ruygrok, Jörg Neuzner, Jan J. Piek, Ashok Seth, Joachim Schofer, Gert Richardt, Marcus Wiemer, Didier Carrié, Leif Thuesen, Els Boone, Karine Miquel-Herbert, Joost Daemen (2006). A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.. PubMed, 2(3), pp. 286-94
Article146 days agoClinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
Javier Escaned, Carlos Collet, Nicola Ryan, Giovanni Luigi De Maria, Simon Walsh, Manel Sabaté, Justin E. Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Stephan P Hoole, Nick E.J. West, Jan J. Piek, Azfar Zaman, Farzin Fath‐Ordoubadi, Rod Stables, Clare Appleby, Nicolas M. Van Mieghem, Robert J. Van Geuns, Neal Uren, Javier Zueco, Paweł Buszman, Andrés Íñiguez, Javier Goicolea, David Hildick‐Smith, Andrzej Ochała, Dariusz Dudek, Colm G. Hanratty, Rafael Cavalcante, A. Pieter Kappetein, David P. Taggart, Gerrit‐Anne van Es, Marie‐Angèle Morel, Ton de Vries, Yoshinobu Onuma, Vasim Farooq, Patrick W. Serruys, Adrian Banning (2017). Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. European Heart Journal, 38(42), pp. 3124-3134, DOI: 10.1093/eurheartj/ehx512.
Article146 days agoProspective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance
Javier Escaned, Mauro Echavarría‐Pinto, Héctor M. García‐García, Tim P. van de Hoef, Ton de Vries, Prashant Kaul, Ganesh Raveendran, John D. Altman, Howard I. Kurz, Johannes Brechtken, Mark Tulli, Clemens von Birgelen, Joel E. Schneider, Ahmed Khashaba, Allen Jeremias, Jim Baucum, Raúl Moreno, Martijn Meuwissen, Gregory Mishkel, Robert‐Jan van Geuns, Howard A. Levite, Ramon López‐Palop, Marc Mayhew, Patrick W. Serruys, Habib Samady, Jan J. Piek, Amir Lerman (2015). Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 8(6), pp. 824-833, DOI: 10.1016/j.jcin.2015.01.029.
Article146 days agoA randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial.
Patrick W. Serruys, Andrew T.L. Ong, Jan J. Piek, Franz‐Josef Neumann, Willem J. van der Giessen, Marcus Wiemer, Andreas M. Zeiher, Eberhard Grube, Jürgen Haase, Leif Thuesen, Christian W. Hamm, Patricia C. Otto-Terlouw (2005). A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial.. PubMed, 1(1), pp. 58-65
Article146 days ago